File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s12072-021-10213-7
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Crowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report
Title | Crowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report |
---|---|
Authors | |
Issue Date | 2021 |
Publisher | Springer (India) Private Ltd. The Journal's web site is located at http://www.springer.com/medicine/internal/journal/12072 |
Citation | Asian Pacific Association for the Study of the Liver (APASL) 30th Annual Meeting 2021: Collaboration and Cure, Virtual Meeting, 4-6 February 2021. In Hepatology International, 2021, v. 15 n. Suppl. 1, p. S28, absract no. G-05 How to Cite? |
Abstract | Objectives: Many people living with HCV in China are unaware of their HCV status, despite a large burden of disease and increasing treatment access. Crowdsourcing has a group of individuals solve a problem (e.g., messaging to promote HCV testing and linkage) and then implement solutions.
Materials and Methods: A two-armed randomized controlled trial is being con ducted at primary care sectors of Shenzhen among local residents >30 years old not known to have HCV. The intervention group would receive crowdsourcing materials to promote HCV testing twice a week for two weeks, while the control group received standard promotional materials. Those identified HCV antibody-positive would be referred to specialists for confirmation and treatment.
Results: As of 4th November 2020, 614 persons were recruited into the study (311 in the intervention group and 303 in the control). 47.1% were male; majority married (81.6%) with an average age of 43.2 years. 490 (79.8%; 249 in the intervention vs 241 in the control) had been tested and 12 (8 in the intervention and 4 in the control) were found to be positive for HCV. Significantly more were tested at HKUSZH in the intervention group (129/179 in the intervention vs 105/197 in the control; p<0.001). In those detected HCV, there were significantly more who did not think HCV was a serious problem before (p=0.048).
Discussion: This interim analysis demonstrates the feasibility and acceptability of this approach. This community-based hospital approach could be used to scale up HCV testing in many settings. (Chinese Clinical Trial Registry ChiCTR19000025771) |
Description | Poster Presentation - Health Services Research - no. G-05 Organizer: Thai Association for Study of the Liver |
Persistent Identifier | http://hdl.handle.net/10722/298667 |
ISSN | 2023 Impact Factor: 5.9 2023 SCImago Journal Rankings: 1.813 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, WCW | - |
dc.contributor.author | Yang, NS | - |
dc.contributor.author | Li, J | - |
dc.contributor.author | Li, H | - |
dc.contributor.author | Wan, EYF | - |
dc.contributor.author | Fitzpatrick, T | - |
dc.contributor.author | Xiong, Y | - |
dc.contributor.author | Chan, P | - |
dc.contributor.author | Liu, R | - |
dc.contributor.author | Tang, WM | - |
dc.contributor.author | Seto, WKW | - |
dc.contributor.author | Tucker, J | - |
dc.date.accessioned | 2021-04-12T03:01:42Z | - |
dc.date.available | 2021-04-12T03:01:42Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Asian Pacific Association for the Study of the Liver (APASL) 30th Annual Meeting 2021: Collaboration and Cure, Virtual Meeting, 4-6 February 2021. In Hepatology International, 2021, v. 15 n. Suppl. 1, p. S28, absract no. G-05 | - |
dc.identifier.issn | 1936-0533 | - |
dc.identifier.uri | http://hdl.handle.net/10722/298667 | - |
dc.description | Poster Presentation - Health Services Research - no. G-05 | - |
dc.description | Organizer: Thai Association for Study of the Liver | - |
dc.description.abstract | Objectives: Many people living with HCV in China are unaware of their HCV status, despite a large burden of disease and increasing treatment access. Crowdsourcing has a group of individuals solve a problem (e.g., messaging to promote HCV testing and linkage) and then implement solutions. Materials and Methods: A two-armed randomized controlled trial is being con ducted at primary care sectors of Shenzhen among local residents >30 years old not known to have HCV. The intervention group would receive crowdsourcing materials to promote HCV testing twice a week for two weeks, while the control group received standard promotional materials. Those identified HCV antibody-positive would be referred to specialists for confirmation and treatment. Results: As of 4th November 2020, 614 persons were recruited into the study (311 in the intervention group and 303 in the control). 47.1% were male; majority married (81.6%) with an average age of 43.2 years. 490 (79.8%; 249 in the intervention vs 241 in the control) had been tested and 12 (8 in the intervention and 4 in the control) were found to be positive for HCV. Significantly more were tested at HKUSZH in the intervention group (129/179 in the intervention vs 105/197 in the control; p<0.001). In those detected HCV, there were significantly more who did not think HCV was a serious problem before (p=0.048). Discussion: This interim analysis demonstrates the feasibility and acceptability of this approach. This community-based hospital approach could be used to scale up HCV testing in many settings. (Chinese Clinical Trial Registry ChiCTR19000025771) | - |
dc.language | eng | - |
dc.publisher | Springer (India) Private Ltd. The Journal's web site is located at http://www.springer.com/medicine/internal/journal/12072 | - |
dc.relation.ispartof | Hepatology International | - |
dc.relation.ispartof | The 30th Asian Pacific Association for the Study of Liver (APASL) Annual Meeting, 2021 | - |
dc.title | Crowdsourcing To Promote Hepatitis C Testing And Linkage-to-care In China: Randomized Controlled Trial Interim Report | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Wong, WCW: wongwcw@hku.hk | - |
dc.identifier.email | Wan, EYF: yfwan@hku.hk | - |
dc.identifier.email | Seto, WKW: wkseto@hku.hk | - |
dc.identifier.authority | Wong, WCW=rp01457 | - |
dc.identifier.authority | Wan, EYF=rp02518 | - |
dc.identifier.authority | Seto, WKW=rp01659 | - |
dc.description.nature | abstract | - |
dc.identifier.hkuros | 322000 | - |
dc.identifier.volume | 15 | - |
dc.identifier.issue | Suppl. 1 | - |
dc.identifier.spage | S28 | - |
dc.identifier.epage | S28 | - |
dc.publisher.place | India | - |
dc.identifier.partofdoi | 10.1007/s12072-021-10213-7 | - |